您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Buflomedil hydrochloride market report

讯：

Buflomedil hydrochloride market report (2007 edition)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  June 2007
Format:  Adobe PDF
Price:  US$ 2,000
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: bianch@healthoo.com   wuhf@healthoo.com 
 
Table of contents
Summary
1 Brief introduce of buflomedil hydrochloride
2 Market analysis of buflomedil hydrochloride
  2.1 Growth trend
  2.2 Sales trend of enterprises and brands from 2002 to 2006
  2.3 Market shares of key brands from 2002 to 2006
    “Fonzylane” (company: Laboratoire　L.Lafon)
    “Yisu”
    “IKELAN”(company: MEDOCHEMIE LTD)
    “Sailaile”
    “BuFuMai”
    “RuiLiDa”
3 Analysis on formulations, specification, price trend
4 Information of researhing and development in China
4.1 Domestic and imported drugs on the market
4.2 Status of application and approval

Tables and figures
Table 1 Sales and gorwth trend from 2002 to 2006
Table 2 Sales rank of enterprises in 2006
Table 3 Market shares of enterprises and brands from 2002 to 2006
Table 4 Sales values in key cities for buflomedil hydrochloride from 2002 to 2006
Table 5 Sales shares in key cities for buflomedil hydrochloride from 2002 to 2006
Table 6 Sales trend of Fonzylane in key cities from 2002 to 2006
Table 7 Sales trend of Yisu in key cities from 2002 to 2006
Table 8 Sales trend of IKELAN in key cities from 2002 to 2006
Table 9 Sales trend of Sailaile in key cities from 2002 to 2006
Table 10 Sales trend of BuFuMai in key cities from 2002 to 2006
Table 11 Sales trend of RuiLiDa in key cities from 2002 to 2006
Table 12 Tetail prices
Table 13 Domestic and import products which marketed and their manufactures
Table 14 The enterprises which are applying the registration of buflomedil hydrochloride

Figure 1 Growth trend from 2002 to 2006
Figure 2 Market shares of key enterprises in 2006
Figure 3 Market shares of key enterprises in 2005
Figure 4 Sales trend of five leading enterprises form 2002 to 2006
Figure 5 Market shares of five leading enterprises form 2002 to 2006
Figure 6 Sales values of buflomedil hydrochloride with different administration ways  form 2002 to 2006
Figure 7 Sales qualities of buflomedil hydrochloride with different administration ways  form 2002 to 2006
Figure 8 Sales values of buflomedil hydrochloride with different specifications form 2002 to 2006
Figure 9 Sales qualities of buflomedil hydrochloride with different specifications form 2002 to 2006